-
Sector Analysis
NewMagnetic Resonance Imaging (MRI) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Magnetic Resonance Imaging (MRI) Systems Market Report Overview The MRI systems market size was $5.73 billion in 2023 and will grow at a CAGR of more than 4% during 2023-2033. The increasing prevalence of the aging population and an increase in awareness regarding the importance of early diagnosis of disease which helps in early treatment will fuel the market growth in the coming years. Magnetic Resonance Imaging Systems Market Outlook 2023-2033 ($ Billion) Buy the Full Report for More Insights...
-
Product Insights
Likelihood of Approval Analysis for Developmental Disorders
Overview How likely is it that the drugs in Developmental Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Developmental Disorders Overview Developmental disorders comprise a spectrum of conditions affecting physical,...
-
Sector Analysis
NewPeru Statutory and Private Employee Benefits, 2024 Update
Peru Statutory and Private Employee Benefits Overview The social security system in Peru is undergoing significant change. The informal nature of the labor market is the reason for low social security contributions. Most workers are self-employed and there are lack of information and valuation within the system. In the early 1990s, the social security system established the Sistema Privado de Pensiones (private pension system, or SPP) to provide benefits in the event of old age, disability, and death. This was...
-
Product Insights
Likelihood of Approval Analysis for Respiratory Distress Syndrome
Overview How likely is it that the drugs in Respiratory Distress Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Distress Syndrome Overview Respiratory distress syndrome (RDS) occurs in babies...
-
Product Insights
Likelihood of Approval Analysis for Ductal Carcinoma
Overview How likely is it that the drugs in Ductal Carcinoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ductal Carcinoma Overview Ductal Carcinoma is early stage of breast cancer where...
-
Product Insights
Likelihood of Approval Analysis for Open-Angle Glaucoma
Overview How likely is it that the drugs in Open-Angle Glaucoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Open-Angle Glaucoma Overview Open-angle glaucoma is a chronic eye condition characterized by...
-
Product Insights
Early Power Bridge Combined Cycle Power Plant
Early Power Bridge Combined Cycle Power Plant is a thermal project located in Greater Accra, Ghana. The project is owned by Endeavor Energy Inc; GE Power; SAGE Petroleum Ltd and is developed by Early Power Ltd. The project is currently partially active. Empower your strategies with our Early Power Bridge Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Product Insights
Likelihood of Approval Analysis for Schizophrenia
Overview How likely is it that the drugs in Schizophrenia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Schizophrenia Overview Schizophrenia is a chronic, severe, and disabling brain disorder that generally...
-
Product Insights
Likelihood of Approval Analysis for Vulvar Cancer
Overview How likely is it that the drugs in Vulvar Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vulvar Cancer Overview Vulvar cancer is a rare type of cancer. It...